Literature DB >> 2872043

The hepatic and renal mechanisms of drug interactions with cimetidine.

M Nazario.   

Abstract

Cimetidine is one of the most frequently prescribed drugs with a known potential to interfere with the metabolic disposition of numerous other medications. Some of these drug interactions may be hazardous to patients. The hepatic and renal mechanisms of drug interactions with cimetidine are discussed in this article. The interactive processes include inhibition of hepatic microsomal enzyme activity, reduction of liver blood flow, and competition for renal tubular secretory sites. The clinical significance and proposed mechanisms of interaction for individual drugs are also presented.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2872043     DOI: 10.1177/106002808602000502

Source DB:  PubMed          Journal:  Drug Intell Clin Pharm        ISSN: 0012-6578


  4 in total

1.  Influence of the H2-receptor antagonists cimetidine and ranitidine on the pharmacokinetics of nimodipine in healthy volunteers.

Authors:  W Mück; W Wingender; M Seiberling; E Woelke; K D Rämsch; J Kuhlmann
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  The influence of ofloxacin and enoxacin on the metabolic pathways of theophylline in healthy volunteers. A pilot study.

Authors:  W J Wijnands; T J Janssen; P J Guelen; T B Vree; T M De Witte
Journal:  Pharm Weekbl Sci       Date:  1988-12-09

3.  The pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen, and their acyl glucuronides in humans. Effect of cimetidine.

Authors:  T B Vree; M Van Den Biggelaar-Martea; C P Verwey-Van Wissen; M L Vree; P J Guelen
Journal:  Br J Clin Pharmacol       Date:  1993-05       Impact factor: 4.335

4.  Influence of partial hepatectomy in rats on the activity of hepatic microsomal enzymatic systems.

Authors:  A M Maza; A R Gascon; M B Calvo; R M Hernandez; M A Monte; J J Marin; A Dominguez-Gil; J L Pedraz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Jan-Mar       Impact factor: 2.569

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.